Drugmakers to Submit Clinical Trial Data on Failed Products Under New Proposed Rule

Drug Industry Daily
Drug and biologic makers would have to submit all clinical trial data to the federal government — including data for products not approved by the FDA — under a massive proposed expansion of data collection.

To View This Article:


Subscribe To Drug Industry Daily